One vax patient's rare journey
An adverse allergic reaction to a covid vaccine is rare, but just how rare remains to be seen. On Wednesday, the National Institutes of Health announced a new study to try to understand the number of people experiencing moderate allergic reaction to mRNA vaccines, and why. Joanne Kenen — who had an allergic reaction to her first Pfizer dose — reports.
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
An adverse allergic reaction to a covid vaccine is rare, but just how rare remains to be seen. On Wednesday, the National Institutes of Health announced a new study to try to understand the number of people experiencing moderate allergic reaction to mRNA vaccines, and why. Joanne Kenen — who had an allergic reaction to her first Pfizer dose — reports.
Learn more about your ad choices. Visit megaphone.fm/adchoices